We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI) (TARGET-PCI)

This study has been terminated.
(Lack of financial support)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01177592
First Posted: August 9, 2010
Last Update Posted: March 19, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Kevin Bliden, LifeBridge Health
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)